Jeena Sikho Lifecare Limited share price

Key numbers

Market cap

₹ 6,318 Cr

Current price

₹ 508.25

52-week high / low

₹ 839 / 485

Stock P/E

26.8

Book value

₹ 37.6

Dividend yield

0.89%

ROCE

64.1%

ROE

61.3%

Debt to equity

0.27

Sales growth (3 yrs)

57.7%

Profit growth (3 yrs)

87.3%

1-year return

-37.5%

About Jeena Sikho Lifecare Limited

Jeena Sikho Lifecare Limited trades in ayurvedic products in India and internationally. It operates through Ayurvedic products/medicine, Ayurvedic healthcare services, and others segments. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-14)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• Revenue from operations grew by 29% YoY in Q1 FY27, supported by higher patient footfalls, expansion of our service network, and continued momentum in our products business.
• Within our Ayurveda healthcare service business, underlying demand remained strong, with Panchakarma revenue growing 13% in Q1 FY27, supported by a 33% YoY increase in IPD patients and a 31% increase in day care volume.

Growth & demand

• If you look at our patient count and volume, overall quarter-on-quarter growth is 10%.
• In Panchakarma sales, private revenue was INR78 crore s, which grew to INR100 crore s this quarter -on-quarter on a year-on-year basis, roughly over 30% growth.

Margins & costs

• In this quarter, our revenue from operations stood at INR224 crores, while EBITDA was INR92 crores and PAT was INR65 crore s.
• We delivered a 41% EBITDA margin and a 28% PAT margin.

Capex & expansion

• When a patient receives clinical outcomes, they feel satisfied with their experience, and that experience becomes a word -of-mouth driver Jeena Sikho Lifecare Limited August 10, 2026 and a channel for new patient acquisition for us.
• Over time, this strengthens customer relationships and improves acquisition economics.

Balance sheet & cash

• The margin performance reflects improving operating leverage, better utilization of our existing infrastructure, and increased scalability across businesses.
• If I continue business where money gets stuck in receivables, that bad debt risk persists.

Peers in Medical Care Facilities

• Apollo Hospitals Enterprise Limited
• Max Healthcare Institute Limited
• Manipal Health Enterprises Limited
• Aster DM Quality Care Limited
• Fortis Healthcare Limited
• Global Health Limited
• Narayana Hrudayalaya Limited
• Krishna Institute of Medical Sciences Limited
• Rainbow Children's Medicare Limited
• Park Medi World Limited